Page last updated: 2024-08-24

valsartan and Malignant Hypertension

valsartan has been researched along with Malignant Hypertension in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Michaud, CJ; Trethowan, B1
Hartner, A; Hilgers, KF; Mann, JF; Porst, M; Veelken, R1

Other Studies

2 other study(ies) available for valsartan and Malignant Hypertension

ArticleYear
Valsartan Effective for Malignant Hypertension after Aortic Dissection with Renal Artery Involvement.
    Pharmacotherapy, 2018, Volume: 38, Issue:4

    Topics: Adult; Antihypertensive Agents; Aortic Dissection; Humans; Hypertension, Malignant; Male; Renal Artery; Valsartan

2018
Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: relation to kidney inflammation.
    Circulation, 2001, Sep-18, Volume: 104, Issue:12

    Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Malignant; Hypertension, Renovascular; Immunohistochemistry; Kidney; Macrophages; Male; Nephritis; Organ Size; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Survival Rate; Tetrazoles; Valine; Valsartan

2001